Ariz. Admin. Code § R9-7-707 - Written Directives
A. A
licensee shall ensure that a written directive is dated and signed by an
authorized user before the administration of I-131 sodium iodide greater than
1.11 MBq (30 microcuries (µCi)), any therapeutic dosage of unsealed radioactive
material or any therapeutic dose of radiation from radioactive material. If,
because of the emergent nature of the patient's condition, a delay in order to
provide a written directive would jeopardize the patient's health, an oral
directive is acceptable. The information contained in the oral directive shall
be documented as soon as possible in writing in the patient's record. A written
directive shall be prepared within 48 hours of the oral directive.
B. A written directive shall contain the
patient or human research subject's name and the following information:
6.
7. For all other brachytherapy, including low, medium,
and pulsed dose rate remote afterloaders:
1. For any administration of quantities
greater than 1.11 MBq (30 µCi) of sodium iodide I-131: the dosage;
2. For an administration of a therapeutic
dosage of unsealed radioactive material other than sodium iodide I-131: the
radiopharma-ceutical, dosage, and route of administration;
3. For gamma stereotactic radiosurgery: the
total dose, treatment site, and values for the target coordinate settings per
treatment for each anatomically distinct treatment site;
4. For teletherapy: the total dose, dose per
fraction, number of fractions, and treatment site;
5. For high dose-rate remote afterloading
brachytherapy: the radionuclide, treatment site, dose per fraction, number of
fractions, and total dose;
6. For
permanent implant brachytherapy:
a. Before
implantation: the treatment site, radionuclide, and total strength;
and
b. After implantation but
before the patient leaves the post-treatment recovery area: the treatment site,
number of sources implanted, total source strength implanted, and date;
or
a.
Before implantation: the treatment site, radionuclide, and dose; and
b. After implantation but before completion
of the procedure: the radionuclide, treatment site, number of sources, total
source strength and exposure time (or the total dose), and date.
C. The licensee shall
retain a copy of the written directive for three years after creation of the
record.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.